Document is current

Any future updates will be listed below

Successful treatment of refractory Sezary syndrome by anti-PD-1 antibody (nivolumab)

Crossref DOI link: https://doi.org/10.1007/s00277-017-2929-6

Published Online: 2017-01-24

Published Print: 2017-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark